Similarly, pharmacologic inhibition of DOT1L’s methyltransferase function shows modest and delayed responses in vitro and in vivo when compared to genetic inactivation that demonstrated DOT1L’s essential function in MLL-rearranged leukemia [147,154,164,172,201,202,203,204]. Here, DOT1L is linked to leukemia.